Although the reason has been unidentified, it is consistent with a previous report demonstrating that the other Btk inhibitor evobrutinib did not reduce anti-collagen antibody production in mice with collagen-induced arthritis [18]. The gene discussed is BTK; the disease is arthritic joint disease.